Journal of Mammary Gland Biology and Neoplasia

, Volume 10, Issue 4, pp 291–298 | Cite as

Multifaceted Role of Rho Proteins in Angiogenesis

  • Sofia D. MerajverEmail author
  • Saad Z. Usmani


The Rho family of GTPases is part of the Ras superfamily. The Rho, Rac, and Cdc42 members of the family are present in mammalian cells and have been the subject of attention of researchers due to their vast spectrum of functions. Rac 1, Cdc42, and RhoA are well-known for their role in the regulation of the actin cytoskeleton in promoting the formation of lamellipodia, filopodia, and stress fibers, respectively. The Rho proteins also participate in the control of cell growth, motility, cell–cell adhesions, morphogenesis, cytoskeletal dynamics, and cellular trafficking. The mechanisms for eliciting these functions have become clearer during the last decade. Concordant with their roles in multiple processes of cellular control, the Rho proteins have been shown to be involved in tumor growth, progression, metastasis, and now angiogenesis.


Cancer Blood vessels Tumor progression Focal adhesions Ras 


  1. 1.
    Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 1972;175:409–16.PubMedGoogle Scholar
  2. 2.
    Veikkola T, Alitalo K. VEGFs, receptors and angiogenesis. Semin Cancer Biol 1999;9:211–20.PubMedGoogle Scholar
  3. 3.
    Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukamoto T, Kumamoto Y, Sugimura T, Terada M. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 1994;54:4233–7.PubMedGoogle Scholar
  4. 4.
    Olson TA, Mohanraj D, Carson LF, Ramakrishnan S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 1994;54:276–80.PubMedGoogle Scholar
  5. 5.
    13 Du JR, Jiang Y, Zhang YM, Fu H. Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas. World J Gastroenterol 2003;9:1604–6.PubMedGoogle Scholar
  6. 6.
    Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992;359:845–8.PubMedGoogle Scholar
  7. 7.
    Gleadle JM, Ratcliffe PJ. Hypoxia and the regulation of gene expression. Mol Med Today 1998;4:122–9.PubMedGoogle Scholar
  8. 8.
    Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999; 15: 551–78.PubMedGoogle Scholar
  9. 9.
    Turcotte S, Desrosiers RR, Beliveau R. HIF-1alpha mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma. J Cell Sci 2003; 116(Pt 11): 2247–60, Jun 1.PubMedGoogle Scholar
  10. 10.
    Hirota K, Semenza GL. Rac1 activity is required for the activation of hypoxia-inducible factor 1. J Biol Chem 2001;276(24):21166–72, Jun 15.PubMedGoogle Scholar
  11. 11.
    Xue Y, Bi F, Liu WC, Pan YL, Han ZY, Liu N, et al. Expressions and activities of Rho GTPases in hypoxia and its relationship with tumor angiogenesis. Zhonghua Zhong Liu Za Zhi 2004;26(9):517–20, Sep, Chinese.Google Scholar
  12. 12.
    van Golen KL, Wu ZF, Qiao XT, Bao L, Merajver SD. RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. Neoplasia 2000;2(5):418–25, Sep–Oct.PubMedGoogle Scholar
  13. 13.
    Wu M, Wu ZF, Kumar-Sinha C, Chinnaiyan A, Merajver SD. RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells. Breast Cancer Res Treat 2004;84(1):3–12, Mar.PubMedGoogle Scholar
  14. 14.
    van Nieuw Amerongen GP, Koolwijk P, Versteilen A, van Hinsbergh VW. Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler Thromb Vasc Biol 2003;23(2):211–7, Feb 1.PubMedGoogle Scholar
  15. 15.
    Gingras D, Lamy S, Beliveau R. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins. Biochem J 2000;348(Pt 2):273–80, Jun 1.PubMedGoogle Scholar
  16. 16.
    Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G11995. Science, 269:1270–2.Google Scholar
  17. 17.
    Yamamoto M, Marui N, Sakai T, Morii N, Kozaki S, Ikai K, Imamura S, Narumiya S. ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. Oncogene 1993; 8:1449–55.PubMedGoogle Scholar
  18. 18.
    Liberto M, Cobrinik D, Minden A. Rho regulates p21(CIP1), cyclin D1, and checkpoint control in mammary epithelial cells. Oncogene 2002;21(10):1590–9, Feb 28.PubMedGoogle Scholar
  19. 19.
    Roovers K, Assoian RK. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. BioEssays 2000;22:818–26.PubMedGoogle Scholar
  20. 20.
    Villalonga P, Guasch RM, Riento K, Ridley, AJ. RhoE inhibits cell cycle progression and Ras-induced transformation. Mol Cell Biol 2004;24:7829–40.PubMedGoogle Scholar
  21. 21.
    Roovers K, Assoian RK. Effects of rho kinase and actin stress fibers on sustained extracellular signal-regulated kinase activity and activation of G(1) phase cyclin-dependent kinases. Mol Cell Biol 2003;23:4283–94.PubMedGoogle Scholar
  22. 22.
    Olson MF, Paterson HF. Marshall CJ. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 1998;394:295–8.PubMedGoogle Scholar
  23. 23.
    Weber JD, Hu W, Jefcoat SC, Raben DM, Baldassare JJ. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27Kip1. J Biol Chem 1997;272:32966–71.PubMedGoogle Scholar
  24. 24.
    Westwick JK, Lambert QT, Clark GJ, et al. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways. Mol Cell Biol 1997;17:1324–35.PubMedGoogle Scholar
  25. 25.
    Page K, Li J, Hodge JA, Liu PT, Vanden Hoek TL, Becker, et al. Characterization of a Rac1 signaling pathway to cyclin D(1) expression in airway smooth muscle cells. J Biol Chem 1999;274:22065–71.PubMedGoogle Scholar
  26. 26.
    Joyce D, Bouzahzah B, Fu M, Albanese C, et al. Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J Biol Chem 1999; 274:25245–9.PubMedGoogle Scholar
  27. 27.
    Welsh CF, Roovers K, Villanueva J, Liu Y, Schwartz MA, Assoian RK. Timing of cyclin D1 expression within G1 phase is controlled by Rho. Nat Cell Biol 2001;3:950–7.PubMedGoogle Scholar
  28. 28.
    Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 1990;11(12):443–9, Dec.PubMedGoogle Scholar
  29. 29.
    Mateo RB, Reichner JS, Albina JE. Interleukin-6 activity in wounds. Am J Physiol 1994;266(6 Pt 2):R1840–4, Jun.PubMedGoogle Scholar
  30. 30.
    Yan SF, Tritto I, Pinsky D, Liao H, Huang J, Fuller G, et al. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem 1995;270(19):11463–71, May 12.PubMedGoogle Scholar
  31. 31.
    Mizukami Y, Jo WS, Duerr EM, Gala M, Li J, Zhang X, et al. Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat Med 2005;11(9): 992–7, Sep.PubMedGoogle Scholar
  32. 32.
    Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996;271(2):736–41, Jan 12.PubMedGoogle Scholar
  33. 33.
    Mukaida N, Matsumoto T, Yokoi K, Harada A, Matsushima K. Inhibition of neutrophil-mediated acute inflammation injury by an antibody against interleukin-8 (IL-8). Inflamm Res 1998; 47:151.Google Scholar
  34. 34.
    Munoz C, Pascual-Salcedo D, Castellanos MC, et al. Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kB and AP-1 transcription factors activity. Blood 1996;88:3480.Google Scholar
  35. 35.
    Montaner S, Perona R, Saniger L, Lacal JC. Multiple signalling pathways lead to the activation of the nuclear factor-kB by the Rho family of GTPases. J Biol Chem 1998;273:12,779.Google Scholar
  36. 36.
    Perona R, Montaner S, Saniger S, Sa´nchez-Pe´rez I, Bravo R, Lacal, JC. Activation of the nuclear factor-kB by Rho, CDC42, and Rac-1 proteins. Genes Dev 1997;11:463.PubMedGoogle Scholar
  37. 37.
    Ito T, Ikeda U, Shimpo M, Ohki R, Takahashi M, Yamamoto K, et al. HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells. Cardiovasc Drugs Ther 2002;16(2):121–6, Mar.PubMedGoogle Scholar
  38. 38.
    Seabra MC. Membrane association and targeting of prenylated Ras-like GTPases. Cell Signal 1998;10(3):167–72, Mar.PubMedGoogle Scholar
  39. 39.
    Guijarro C, Blanco-Colio LM, Ortego M, et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ Res 1998;83:490–500.PubMedGoogle Scholar
  40. 40.
    Guijarro C, Blanco-Colio LM, Massy ZA, et al. Lipophilic statins induce apoptosis of human vascular smooth muscle cells. Kidney Int 1999;71:S88–91.Google Scholar
  41. 41.
    Vincent L, Chen W, Hong L, Mirshahi F, Mishal Z, Mirshahi-Khorassani T, et al. Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect. FEBS Lett 2001;495(3):159–66, Apr 27.PubMedGoogle Scholar
  42. 42.
    Faruqi TR, Gomez D, Bustelo XR, Bar-Sagi D, Reich NC. Rac1 mediates STAT3 activation by autocrine IL-6. Proc Natl Acad Sci USA 2001;98(16):9014–9, Jul 31.PubMedGoogle Scholar
  43. 43.
    Warny M, Keates AC, Keates S, Castagliuolo I, Zacks JK, Aboudola S, et al. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J Clin Invest 2000;105(8):1147–56, Apr.PubMedCrossRefGoogle Scholar
  44. 44.
    Hippenstiel S, Soeth S, Kellas B, Fuhrmann O, Seybold J, Krull M, et al. Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood 2000;95(10):3044–51, May 15.PubMedGoogle Scholar
  45. 45.
    Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res 1992;59:115–65.PubMedCrossRefGoogle Scholar
  46. 46.
    Payson RA, Chotani MA, Chiu IM. Regulation of a promoter of the fibroblast growth factor 1 gene in prostate and breast cancer cells. J Steroid Biochem Mol Biol 1998;66(3):93–103, Aug.PubMedGoogle Scholar
  47. 47.
    Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 1994;86:356–61.PubMedGoogle Scholar
  48. 48.
    Chotani MA, Touhalisky K, Chiu IM. The small GTPases Ras, Rac, and Cdc42 transcriptionally regulate expression of human fibroblast growth factor 1. J Biol Chem 2000;275(39):30432–8, Sep 29.PubMedGoogle Scholar
  49. 49.
    Liu JF, et al. Functional Rac-1 and Nck signaling networks are required for FGF-2-induced DNA synthesis in MCF-7 cells. Oncogene 1999;18(47):6425–33, Nov 11.PubMedGoogle Scholar
  50. 50.
    Jackson TA, Koterwas DM, Morgan MA, Bradford AP. Fibroblast growth factors regulate prolactin transcription via an atypical Rac-dependent signaling pathway. Mol Endocrinol 2003;17(10):1921–30, Oct.PubMedGoogle Scholar
  51. 51.
    Watnick RS, Cheng YN, Rangarajan A, Ince TA, Weinberg RA.Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell 2003;3(3):219–31, Mar.PubMedGoogle Scholar
  52. 52.
    Schwartz MA, Shattil SJ. Signaling networks linking integrins and rho family GTPases. Trends Biochem Sci 2000;25(8):388–91, Aug.PubMedGoogle Scholar
  53. 53.
    Burridge K, Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 1996;12:463–518.PubMedGoogle Scholar
  54. 54.
    del Pozo MA, Price LS, Alderson NB, Ren XD, Schwartz MA. Adhesion to the extracellular matrix regulates the coupling of the small GTPase Rac to its effector PAK. EMBO J 2000;19(9): 2008–14, May 2.PubMedGoogle Scholar
  55. 55.
    Price LS, Leng J, Schwartz MA, Bokoch GM. Activation of Rac and Cdc42 by integrins mediates cell spreading. Mol Biol Cell 1998;9(7):1863–71, Jul.PubMedGoogle Scholar
  56. 56.
    20 Yron I, et al. Integrin-dependent tyrosine phosphorylation and growth regulation by Vav. Cell Adhes Commun 1999;7:1–11.PubMedGoogle Scholar
  57. 57.
    Cichowski K, et al. Thrombin receptor activation and integrin engagement stimulate tyrosine phosphorylation of the proto-oncogene product, p95vav, in platelets. J Biol Chem 1996; 271:7544–750.PubMedGoogle Scholar
  58. 58.
    Gotoh A, et al. Cross-linking of integrins induces tyrosine phosphorylation of the proto-oncogene product Vav and the protein tyrosine kinase Syk in human factor dependent myeloid cells. Cell Growth Differ 1997;6:721–9.Google Scholar
  59. 59.
    Miranti CK, et al. Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1. Curr Biol 1998;8:1289–99.PubMedGoogle Scholar
  60. 60.
    Ren XD, Kiosses WB, Schwartz MA. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J 1999;18(3):578–85, Feb 1.PubMedGoogle Scholar
  61. 61.
    Miao H, Li S, Hu YL, Yuan S, Zhao Y, Chen BP, et al. Differential regulation of Rho GTPases by beta1 and beta3 integrins: the role of an extracellular domain of integrin in intracellular signaling. J Cell Sci 2002;115(Pt 10):2199–206, May 15.PubMedGoogle Scholar
  62. 62.
    Butler B, Williams MP, Blystone SD. Ligand-dependent activation of integrin alpha vbeta 3. J Biol Chem 2003;278(7):5264–70, Feb 4.PubMedGoogle Scholar
  63. 63.
    Danen EH, Sonneveld P, Brakebusch C, Fassler R, Sonnenberg A. The fibronectin-binding integrins alpha5beta1 and alphavbeta3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis. J Cell Biol 2002;159(6):1071–86, Dec 23.PubMedGoogle Scholar
  64. 64.
    Danen EH, van Rheenen J, Franken W, Huveneers S, Sonneveld P, Jalink K, Sonnenberg A. Integrins control motile strategy through a Rho-cofilin pathway. J Cell Biol 2005;169(3):515–26, May 9.PubMedGoogle Scholar
  65. 65.
    Sahai E, Marshall CJ. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 2003;5(8):711–9, Aug.PubMedGoogle Scholar
  66. 66.
    Dolfi F, et al. The adaptor protein Crk connects multiple cellular stimuli to the JNK signaling pathway. Proc Natl Acad Sci USA 1998;95:15394–9.PubMedGoogle Scholar
  67. 67.
    Clark EA, et al. Integrin-mediated signals regulated by members of the rho family of GTPases. J Cell Biol 1998;142:573–86.PubMedGoogle Scholar
  68. 68.
    Yang W, et al. Activation of the Cdc42-associated tyrosine kinase-2 (ACK-2) by cell adhesion via integrin beta1. J Biol Chem 1999;274:8524–30.PubMedGoogle Scholar
  69. 69.
    Barry ST, et al. Requirement for Rho in integrin signalling. Cell Adhes Commun 1997;4:387–98.PubMedGoogle Scholar
  70. 70.
    Renshaw MW, et al. Involvement of the small GTPase rho in integrin-mediated activation of mitogen activated protein kinase. J Biol Chem 1996;271:21691–4.PubMedGoogle Scholar
  71. 71.
    Chong LD, et al. The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells. Cell 1994;79:507–13.PubMedGoogle Scholar
  72. 72.
    Cary LA, et al. Integrin-mediated signal transduction pathways. Histol. Histopathol 1999;14:1001–9.PubMedGoogle Scholar
  73. 73.
    Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999;285: 1028–32.PubMedGoogle Scholar
  74. 74.
    Kiosses WB, Shattil SJ, Pampori N, Schwartz MA. Rac recruits high-affinity integrin alphavbeta3 to lamellipodia in endothelial cell migration. Nat Cell Biol 2001;3(3):316–20, Mar.PubMedGoogle Scholar
  75. 75.
    Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249–57.PubMedGoogle Scholar
  76. 76.
    Ridley AJ. Rho GTPases and cell migration. J Cell Sci 2001;114(Pt 15):2713–22, Aug.PubMedGoogle Scholar
  77. 77.
    Pollard TD, Blanchoin L, Mullins RD. Molecular mechanisms controlling actin filament dynamics in nonmuscle cells. Annu Rev Biophys Biomol Struct 2000;29:545–76.PubMedGoogle Scholar
  78. 78.
    Takenawa T, Miki H. J Cell Sci 2001;114:1801–9.PubMedGoogle Scholar
  79. 79.
    Allen WE, Zicha D, Ridley AJ, Jones GE. A role for Cdc42 in macrophage chemotaxis. J Cell Biol 1998;141(5):1147–57, Jun 1.PubMedGoogle Scholar
  80. 80.
    Nobes CD, Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 1999;144(6):1235–44, Mar 22.PubMedGoogle Scholar
  81. 81.
    Miki H, et al. IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling. Nature 2000;408:732–5.PubMedGoogle Scholar
  82. 82.
    Govind S, Kozma R, Monfries C, Lim L, Ahmed S. Cdc42hs facilitates cytoskeletal reorganization and neurite outgrowth by localizing the 58-kD insulin receptor substrate to filamentous actin. J Cell Biol 2001;152:579–94.PubMedGoogle Scholar
  83. 83.
    Hall A, Rho GTPases and the actin cytoskeleton. Science 1998;279(5350):509–14, Jan 23.PubMedGoogle Scholar
  84. 84.
    Carpenter CL, Tolias KF, Van Vugt A, Hartwig J. Lipid kinases are novel effectors of the GTPase Rac1. Adv Enzyme Regul 1999;39:299–312.PubMedGoogle Scholar
  85. 85.
    Tolias KF, Hartwig JH, Ishihara H, Shibasaki Y, Cantley LC, Carpenter CL. Type I alpha phosphatidylinositol-4-phosphate 5-kinase mediates Rac-dependent actin assembly. Curr Biol 2000;10:153–6.PubMedGoogle Scholar
  86. 86.
    Stanyon CA, Bernard O. LIM-kinase1. Int. J Biochem Cell Biol 1999;31:389–94.PubMedGoogle Scholar
  87. 87.
    Edwards DC, Sanders LC, Bokoch GM, Gill GN. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling toactin cytoskeletal dynamics. Nat Cell Biol 1999;1:253–9.PubMedGoogle Scholar
  88. 88.
    van Leeuwen FN, van Delft S, Kain HE, van der Kammen RA, Collard JG. Rac regulates phosphorylation of the myosin-II heavy chain, actinomyosin disassembly and cell spreading. Nat Cell Biol 1999;1:242–8.PubMedGoogle Scholar
  89. 89.
    Daniels RH, Bokoch GM. p21-activated protein kinase: a crucial component of morphological signaling? Trends Biochem Sci 1999;24:350–5.PubMedGoogle Scholar
  90. 90.
    Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996;84:359–69.PubMedGoogle Scholar
  91. 91.
    Nobes CD, Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995;81:53–62.PubMedGoogle Scholar
  92. 92.
    Allen WE, Jones GE, Pollard JW, Ridley AJ. Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages. J Cell Sci 1997;110:707–20.PubMedGoogle Scholar
  93. 93.
    Kaibuchi K, Kuroda S, Fukata M, Nakagawa M. Regulation of cadherin-mediated cell–cell adhesion by the Rho family GTPases. Curr Opin Cell Biol 1999;11(5):591–6, Oct.PubMedGoogle Scholar
  94. 94.
    Cox EA, Huttenlocher A. Regulation of integrin-mediated adhesion during cell migration. Microsc Res Tech 1998;3:412–9.Google Scholar
  95. 95.
    Kirchhausen T, et al. Disease mechanism: unravelling Wiskott–Aldrich syndrome. Curr Biol 1996;6:676–8.PubMedGoogle Scholar
  96. 96.
    Davis GE, Camarillo C. An a2β1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp Cell Res 1996;224:39–51.PubMedGoogle Scholar
  97. 97.
    Bayless KJ, Salazar R, Davis GE. RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins. Am J Pathol 2000;156(5):1673–83, May.PubMedGoogle Scholar
  98. 98.
    Davis GE, Black SM, Bayless KJ. Capillary morphogenesis during human endothelial cell invasion of three-dimensional collagen matrices. In Vitro Cell Dev Biol 2000;36:513–9.Google Scholar
  99. 99.
    Liu BP, Chrzanowska-Wodnicka M, Burridge K. Microtubule depolymerization induces stress fibers, focal adhesions, and DNA synthesis via the GTP-binding protein Rho. Cell Adhes Commun 1998;5:249–55.PubMedCrossRefGoogle Scholar
  100. 100.
    Inada H, Togashi H, Nakamura Y, Kaibuchi K, Nagata K, Inagaki M. Balance between activities of Rho kinase and type 1 protein phosphatase modulates turnover of phosphorylation and dynamics of desmin/vimentin filaments. J Biol Chem 1999; 274:34932–9.PubMedGoogle Scholar
  101. 101.
    Goode BL, Drubin DG, Barnes F. Functional cooperation between the microtubule and actin cytoskeletons. Curr Opin Cell Biol 2000;12:63–71.PubMedGoogle Scholar
  102. 102.
    Meriane M, Mary S, Comunale F, Vifnal E, Fort P, Gauthier-Rouviere C. Cdc42Hs and Rac1 GTPases induce collapse of the vimentin intermediate filament network. J Biol Chem 2000; 275:33046–52.PubMedGoogle Scholar
  103. 103.
    Tian L, Nelson DL, Stewart DM. Cdc42-interacting protein 4 mediates binding of the Wiskott–Aldrich syndrome protein to microtubules. J Biol Chem 2000;275:7854–61.PubMedGoogle Scholar
  104. 104.
    Daub H, Gavaert K, Vandekerchkhove J, Sobel A, Hall A. Rac/Cdc42 and p65PAK regulate the microtubule-destabilizing protein stathmin through phosphorylation and serine 16. J Biol Chem 2001;276:1677–80.PubMedGoogle Scholar
  105. 105.
    Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992;70:401–10.PubMedGoogle Scholar
  106. 106.
    Caron E, Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998;282(5394):1717–21, Nov 27.PubMedGoogle Scholar
  107. 107.
    Chimini G, Chavrier P. Function of Rho family proteins in actin dynamics during phagocytosis and engulfment. Nat Cell Biol 2000;2(10):E191–6, Oct.PubMedGoogle Scholar
  108. 108.
    Garrett WS, Chen LM, Kroschewski R, Ebersold M, Turley S, Trombetta S, et al. Developmental control of endocytosis in dendritic cells by Cdc42. Cell 2000;102(3):325–34, Aug 4.PubMedGoogle Scholar
  109. 109.
    Somlyo AV, Bradshaw D, Ramos S, Murphy C, Myers CE, Somlyo AP. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun 2000;269:652–9.PubMedGoogle Scholar
  110. 110.
    Bayless KJ, Davis GE. The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. J Cell Sci 2002;115(Pt 6):1123–36, Mar 15.PubMedGoogle Scholar
  111. 111.
    Davis GE, Bayless KJ. An integrin and Rho GTPase-dependent pinocytic vacuole mechanism controls capillary lumen formation in collagen and fibrin matrices. Microcirculation 2003;10(1):27–44, Jan.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  1. 1.Breast and Ovarian Cancer Risk Evaluation ProgramUniversity of Michigan Comprehensive Cancer CenterAnn ArborUSA
  2. 2.Department of MedicineOakwood HospitalDearbornUSA

Personalised recommendations